Jing Chen Xiao

823 citations

20 papers · 313 indexed · h-index 12

Co-authors: Tung M. Fong Chun-Pyn Shen William K. Hagmann Julie Lao Xinchun Tong Junying Wang Thomas F. Walsh Linus S. Lin
Topics: Cannabis and Cannabinoid Research (12 papers)Neuroscience and Neuropharmacology Research (7 papers)Antibiotic Resistance in Bacteria (5 papers)
Cited by: Pharmacology Molecular Medicine Applied Microbiology and Biotechnology
Journals: Brain Research Journal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy
Partner nations: United States China France

In The Last Decade

Jing Chen Xiao

20 papers receiving 307 citations

Peers

Countries citing papers authored by Jing Chen Xiao

Since Specialization

Citations

This map shows the geographic impact of Jing Chen Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Chen Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Chen Xiao more than expected).

Fields of papers citing papers by Jing Chen Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Chen Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Chen Xiao. The network helps show where Jing Chen Xiao may publish in the future.

Co-authorship network of co-authors of Jing Chen Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Chen Xiao. A scholar is included among the top collaborators of Jing Chen Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Chen Xiao. Jing Chen Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas Aeruginosa 2020 ·Open Forum Infectious Diseases ·Donna Carr,Zufei Zhang,Qian Si,Fred Racine,Jing Chen Xiao,(unknown),Michael K. Wismer,Matthew G. Johnson,Hwa-ping Feng,Katherine Young,Matthew L. Rizk,Mary Motyl	3
2	Exploring the Pharmacokinetic/Pharmacodynamic Relationship of Relebactam (MK-7655) in Combination with Imipenem in a Hollow-Fiber Infection Model 2018 ·Antimicrobial Agents and Chemotherapy ·Jin Wu,Fred Racine,Michael K. Wismer,Katherine Young,Donna Carr,Jing Chen Xiao,(unknown),Qian Si,Paul Harradine,Mary Motyl,(unknown),Matthew L. Rizk	46
3	Some Results on Pareto Optimal Choice Sets for Estimating Main Effects and Interactions in 2 n and 3 n Factorial Plans 2017 ·Sankhya B ·Jing Chen Xiao,(unknown)	1
4	Discovery of potent wall teichoic acid early stage inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Marc Labroli,John P. Caldwell,Christine Yang,Sang Ho Lee,Hao Wang,Sandra Koseoglu,Paul A. Mann,Shu‐Wei Yang,Jing Chen Xiao,Charles G. Garlisi,Christopher M. Tan,Terry Roemer,Jing Su	9
5	Benzimidazole analogs as WTA biosynthesis inhibitors targeting methicillin resistant Staphylococcus aureus 2016 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang,Jianping Pan,Christine Yang,Marc Labroli,Weidong Pan,John P. Caldwell,Sookhee Ha,Sandra Koseoglu,Jing Chen Xiao,Todd Mayhood,Payal R. Sheth,Charles G. Garlisi,Jin Wu,Sang Ho Lee,Hao Wang,Christopher M. Tan,Terry Roemer,Jing Su	11
6	Identification and Validation Novel of VIM‐2 Metallo‐β‐lactamase Tripeptide Inhibitors 2015 ·Molecular Informatics ·Jing Chen Xiao,(unknown),Yun Shi,Hui Chen,(unknown),Jiao Chen,Xingzhen Lao,Hanmei Xu,Heng Zheng	5
7	MK-7128, a novel CB1 receptor inverse agonist, improves scopolamine-induced learning and memory deficits in mice 2011 ·Behavioural Pharmacology ·Gregory M. Dillon,Laura S. Lubbers,(unknown),Julie Lao,Ruey-Ruey C. Huang,Jing Chen Xiao,Tung M. Fong,Jeffrey J. Hale,Kathleen M. Rupprecht,(unknown),Blake A. Rowe,Thomas Kornecook,Jean‐Cosme Dodart	9
8	Furo[2,3-b]pyridine-based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation. Part 1 2010 ·Bioorganic & Medicinal Chemistry Letters ·John S. Debenham,(unknown),(unknown),Thomas F. Walsh,Junying Wang,Xinchun Tong,Sanjeev Kumar,Julie Lao,Tung M. Fong,Jing Chen Xiao,(unknown),Chun-Pyn Shen,Yue Feng,Donald J. Marsh,D. Sloan Stribling,Lauren P. Shearman,Alison M. Strack,Mark T. Goulet	25
9	Dihydro-pyrano[2,3-b]pyridines and tetrahydro-1,8-naphthyridines as CB1 receptor inverse agonists: Synthesis, SAR and biological evaluation 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),John S. Debenham,Thomas F. Walsh,Lin Yan,(unknown),Junying Wang,Xinchun Tong,Julie Lao,Tung M. Fong,Jing Chen Xiao,(unknown),Chun-Pyn Shen,D. Sloan Stribling,Lauren P. Shearman,Alison M. Strack,Mark T. Goulet,Jeffrey J. Hale	8
10	Discovery ofN-[(4R)-6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist for the Treatment of Obesity 2010 ·Journal of Medicinal Chemistry ·Lin Yan,(unknown),John S. Debenham,(unknown),Julie Lao,Richard Z. Chen,Jing Chen Xiao,Chun-Pyn Shen,D. Sloan Stribling,Lauren P. Shearman,Alison M. Strack,Nancy N. Tsou,Richard G. Ball,Junying Wang,Xinchun Tong,Thomas J. Bateman,(unknown),Tung M. Fong,Jeffrey J. Hale	15
11	Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation 2009 ·Bioorganic & Medicinal Chemistry Letters ·John S. Debenham,(unknown),Junying Wang,Xinchun Tong,Julie Lao,Tung M. Fong,Marie‐Therese Schaeffer,Jing Chen Xiao,(unknown),Chun-Pyn Shen,D. Sloan Stribling,Lauren P. Shearman,Alison M. Strack,D. Euan MacIntyre,Jeffrey J. Hale,Thomas F. Walsh	16
12	Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists 2009 ·Bioorganic & Medicinal Chemistry Letters ·Wu Du,James P. Jewell,Linus S. Lin,Vincent J. Colandrea,Jing Chen Xiao,Julie Lao,Chun-Pyn Shen,Thomas J. Bateman,(unknown),Sookhee Ha,Shrenik K. Shah,Tung M. Fong,Jeffrey J. Hale,William K. Hagmann	7
13	Pharmacological efficacy and safety profile of taranabant in preclinical species 2009 ·Drug Development Research ·Tung M. Fong,Lauren P. Shearman,D. Sloan Stribling,(unknown),(unknown),(unknown),Jing Chen Xiao,Chun-Pyn Shen,(unknown),Alison M. Strack,Christopher D. DeMaula,(unknown),(unknown),Robert M. Owen,Anna Huber,(unknown)	12
14	Similar in vitro pharmacology of human cannabinoid CB1 receptor variants expressed in CHO cells 2008 ·Brain Research ·Jing Chen Xiao,James P. Jewell,Linus S. Lin,William K. Hagmann,Tung M. Fong,Chun-Pyn Shen	15
15	Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor 2008 ·European Journal of Pharmacology ·Richard Z. Chen,Andrea Frassetto,Julie Lao,Ruey-Ruey C. Huang,Jing Chen Xiao,(unknown),Thomas F. Walsh,Jeffrey J. Hale,Junying Wang,Xinchun Tong,Tung M. Fong	38
16	Conformational Analysis and Receptor Docking of N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (Taranabant, MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist 2008 ·Journal of Medicinal Chemistry ·Linus S. Lin,Sookhee Ha,Richard G. Ball,Nancy N. Tsou,Laurie A. Castonguay,George A. Doss,Tung M. Fong,Chun-Pyn Shen,Jing Chen Xiao,Mark T. Goulet,William K. Hagmann	32
17	Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),John S. Debenham,Thomas F. Walsh,(unknown),(unknown),Junying Wang,Xinchun Tong,Julie Lao,Tung M. Fong,Marie‐Therese Schaeffer,Jing Chen Xiao,(unknown),Chun-Pyn Shen,D. Sloan Stribling,Lauren P. Shearman,Alison M. Strack,D. Euan MacIntyre,Lex H.T. Van der Ploeg,Mark T. Goulet	11
18	Effects of mutations at conserved TM II residues on ligand binding and activation of mouse 5-HT6 receptor 2006 ·European Journal of Pharmacology ·Ping Zhang,Chun-Pyn Shen,Jing Chen Xiao,Thomas J. Lanza,Linus S. Lin,Barbara Francis,Tung M. Fong,Richard Z. Chen	11
19	F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist 2006 ·European Journal of Pharmacology ·Chun-Pyn Shen,Jing Chen Xiao,(unknown),William K. Hagmann,Tung M. Fong	18
20	Synthesis of functionalized 1,8-naphthyridinones and their evaluation as novel, orally active CB1 receptor inverse agonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·John S. Debenham,(unknown),Thomas F. Walsh,Junying Wang,Xinchun Tong,George A. Doss,Julie Lao,Tung M. Fong,Marie‐Therese Schaeffer,Jing Chen Xiao,(unknown),Chun-Pyn Shen,Yue Feng,Donald J. Marsh,D. Sloan Stribling,Lauren P. Shearman,Alison M. Strack,D. Euan MacIntyre,Lex H.T. Van der Ploeg,Mark T. Goulet	21

About Jing Chen Xiao

Jing Chen Xiao is a scholar working on Molecular Medicine, Pharmacology and Cellular and Molecular Neuroscience, having authored 20 papers that have together received 313 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (12 papers), Neuroscience and Neuropharmacology Research (7 papers) and Antibiotic Resistance in Bacteria (5 papers). The work is most often cited by research in Pharmacology (197 citations), Molecular Medicine (55 citations) and Applied Microbiology and Biotechnology (18 citations). Jing Chen Xiao has collaborated with scholars based in United States, China and France. Frequent co-authors include Tung M. Fong, Chun-Pyn Shen, William K. Hagmann, Julie Lao, Xinchun Tong, Junying Wang, Thomas F. Walsh, Linus S. Lin, Jeffrey J. Hale and D. Sloan Stribling. Their work appears in journals such as Brain Research, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact